Your browser doesn't support javascript.
'All In': a pragmatic framework for COVID-19 testing and action on a global scale.
Pettit, Syril D; Jerome, Keith R; Rouquié, David; Mari, Bernard; Barbry, Pascal; Kanda, Yasunari; Matsumoto, Mineo; Hester, Susan; Wehmas, Leah; Botten, Jason W; Bruce, Emily A.
  • Pettit SD; Health and Environmental Sciences Institute, Washington, DC, USA.
  • Jerome KR; Virology Division, Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
  • Rouquié D; SAS Bayer Crop Science, Sophia Antipolis, France.
  • Mari B; Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), CNRS, Université Côte d'Azur, Valbonne, France.
  • Barbry P; Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), CNRS, Université Côte d'Azur, Valbonne, France.
  • Kanda Y; National Institute of Health Sciences, Kanagawa, Japan.
  • Matsumoto M; Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Hester S; Office of Research and Development, Environmental Protection Agency, Research Triangle Park, NC, USA.
  • Wehmas L; Office of Research and Development, Environmental Protection Agency, Research Triangle Park, NC, USA.
  • Botten JW; Division of Immunobiology, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
  • Bruce EA; Division of Immunobiology, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
EMBO Mol Med ; 12(6): e12634, 2020 06 08.
Article in English | MEDLINE | ID: covidwho-197868
ABSTRACT
Current demand for SARS-CoV-2 testing is straining material resource and labor capacity around the globe. As a result, the public health and clinical community are hindered in their ability to monitor and contain the spread of COVID-19. Despite broad consensus that more testing is needed, pragmatic guidance toward realizing this objective has been limited. This paper addresses this limitation by proposing a novel and geographically agnostic framework (the 4Ps framework) to guide multidisciplinary, scalable, resource-efficient, and achievable efforts toward enhanced testing capacity. The 4Ps (Prioritize, Propagate, Partition, and Provide) are described in terms of specific opportunities to enhance the volume, diversity, characterization, and implementation of SARS-CoV-2 testing to benefit public health. Coordinated deployment of the strategic and tactical recommendations described in this framework has the potential to rapidly expand available testing capacity, improve public health decision-making in response to the COVID-19 pandemic, and/or to be applied in future emergent disease outbreaks.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Global Health / Coronavirus Infections Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: EMBO Mol Med Journal subject: Molecular Biology Year: 2020 Document Type: Article Affiliation country: Emmm.202012634

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Global Health / Coronavirus Infections Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: EMBO Mol Med Journal subject: Molecular Biology Year: 2020 Document Type: Article Affiliation country: Emmm.202012634